Binding peptidomimetics and uses of the same

Details Binding peptidomimetics and uses of the same Binding peptidomimetics and uses of the same

2011-03-15

2011-03-15

Desai, Anand U (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S808000, C435S069100, C435S440000, C435S007600

Reexamination Certificate

active

07906624

ABSTRACT:
A multimeric peptidomimetic that comprises two or more monomers is disclosed. The monomers comprise an exocyclic peptide comprising a ring structure, a flexible linker sequence and a multimeric motif. Use of the monomers, a nucleic acid molecule encoding monomers, recombinant expression vectors comprising the nucleic acid molecule and host cells comprising a recombinant expression vector are disclosed. Methods of delivering a drug, a toxin, a nucleic acid molecule, a radionuclide or a detectable compound to a cell are disclosed.

REFERENCES:
patent: 5328985 (1994-07-01), Sano et al.
patent: 5334702 (1994-08-01), Greene et al.
patent: 5663144 (1997-09-01), Greene et al.
patent: 5665539 (1997-09-01), Sano et al.
patent: 5919764 (1999-07-01), Greene et al.
patent: 5922553 (1999-07-01), Eberwine et al.
patent: 6022523 (2000-02-01), Degrado et al.
patent: 6100377 (2000-08-01), Greene et al.
patent: 6391590 (2002-05-01), Sano et al.
patent: 6413934 (2002-07-01), Stayton et al.
patent: 6451995 (2002-09-01), Cheung et al.
patent: 6497881 (2002-12-01), Meruelo et al.
patent: 6743592 (2004-06-01), Greene et al.
patent: 7045286 (2006-05-01), Greene et al.
patent: 7144991 (2006-12-01), Goshorn et al.
patent: 2002/0094534 (2002-07-01), Greene et al.
patent: 2003/0148932 (2003-08-01), Greene et al.
patent: WO 9933965 (1999-07-01), None
patent: WO 02/066980 (2002-08-01), None
patent: WO 02066980 (2002-08-01), None
Murali, R. et al., “Antibody like peptidomimetics as large scale immunodetection prodes,” Cellular and Molecular Biology, Mar. 2003, 49(2), 209-216.
Berezov, A. et al., “Disabling ErbB Receptors with Rationally Designed Exocyclic Mimetics of Antibodies: Structure-Function Analysis,” J. Med. Chem., 2001, 44, 2565-2574.
Park, B-W, et al., “Rationally designed anti-HER2
eu peptide mimetic disables P185 (HER2
eu lyrosine kinases in vitro and in vivo,” Nature Biotechnology, Feb. 2000, 18, 194-198.
Argarana, et al., “Molecular cloning and nucleotide sequence of the streptavidin gene,”Nucleic Acids Res.(1986), 14 (4): 1871-1882.
Chirinos-Rojas, C.L. et al., “A peptidomimetic antagonist of TNF-alpha-mediated cytotoxicity identified from a phage-displayed random peptide library,”J Immunol.(1998), 161(10):5621-6.
Dubel, S. et al., “Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv).,”J Immunol Methods(1995), 178(2):201-9.
Felix, A.M., “Applications of BOP reagent in solid phase synthesis”, Int. J. Pep. Prot. Res. 1988 31:231-238.
Giralt, E. and Andrea eds,In Peptides, ESCOM, Leiden, The Netherlands 1991,131-133.
Hruby, “Conformational restrictions of biologically active peptides via amino acid side chain groups,”Life Sci.(1982)31: 189-199.
Karp, et al., “Identification of biotinylated molecules using a baculovirus-expressed luciferase-streptavidin fusion protein,”Biotechniques(1996), 20 (3):452-456, 458-459.
Kipriyanov, et al., “Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion,”Protein Eng.(1996), 9 (2): 203-211.
Krpriyanov, et al., “Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen,”Hum. Antibodies Hybridomas(1995), 6 (3): 93-101.
Kishore et al., “A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway,”J. Immunol(2001) 166: 559-565.
Koo, et al., “Development of a streptavidin-conjugated single-chain antibody that bindsBacillus cereusspores,”Applied Environ. Microbiol.(1998), 64(7): 2497-2502.
Le, et al., “A streptavidin-cellulose-binding domain fusion protein that binds biotinylated proteins to cellulose,”Enzyme Microb. Technol.16 (6): 496-500,1994.
Lee, W. et al., “Solution structure of the tetrameric minimum transforming domain of p53,”Nature Struct. Biol.(1994),1:877-890.
Murali et al.,“Structure-based design of immunologically active therapeutic peptides,”Immunol. Res.(1998) 17: 163-169.
Ohno and Meruelo, “Multi-drug delivery system using streptavidin-transforming growth factor—alpha chimeric protein,”DNA Cell Biol.(1996), 15 (5): 401-406.
Ohno, et al., “Cell-specific, multidrug delivery system using streptavidin-protein A fusion protein,”Biochem. Mol. Med.(1996)58 (2): 227-233.
Pearce, et al. “Linear gene fusions of antibody fragments with streptavidin can be linked to biotin labelled secondary molecules to form bispecific reagents,”Biochem. Mol. Biol. Int.(1997)42 (6): 1179-1188.
Ploux, 0. et al., “Cyclization of peptides on a solid support. Application to cyclic analogs of substance P,”Int. J. Pep. Prot. Res.(1987), 29: 162-169.
Porstmann, T. et al., “Enzyme immunoassay techniques. An overview,”J Immunol Methods.(1992), 150(1-2):5-21.
Porstmann, B. et al., “Which of the commonly used marker enzymes gives the best results in colorimetric and fluorimetric enzyme immunoassays: horseradish peroxidase, alkaline phosphatase or beta-galactosidase?”J Immunol Methods(1985), 79(1):27-37.
Prasad et al., “Contrasting solution conformations of peptides containing alpha,alpha-dialkylated residues with linear and cyclic side chains,”Biopolymers(1995) 35: 11-20.
Rogers et al., “Characterization of disulfide crosslink formation of human vimentin at the dimer, tetramer, and intermediate filament levels,”J Struct Biol.Jul.-Aug. 1996; 117 (1) : 55-69.
Roland J, et al., “The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression,”DNA Cell Biol., Nov. 1999 18(11):819-28.
Romani, S. et al., “Synthesis of the trypsin fragment 10-25/75-88 of mouse nerve growth factor. II. The unsymmetrical double chain cystine peptide,”Int. J. Pep. Prot. Res.(1987), 29: 107-117).
Sano and Cantor, “Expression of a cloned streptavidin gene inEscherichia coli,” Proc. Natl. Acad. Sci. USA(1990), 87 (1) : 142-146.
Sano and Cantor, “A streptavidin-protein A chimera that allows one-step production of a variety of specific antibody conjugates,”Biotechnology(1991), 1378-1381.
Sano and Cantor, “Expression vectors for streptavidin-containing chimeric proteins,”Biochem. Biophys. Res. Commun(1991), 176 (2): 571-577.
Sano et al., “A streptavidin-metallothionein chimera that allows specific labeling of biological materials with many different heavy metal ions,”Proc. Natl. Acad. Sci. USA(1998), 89 (5): 1534-1538.
Saragovi et al., “Design and synthesis of a mimetic from an antibody complementarity-determining region,”Science(1991), 253: 792-795.
Schiller et al., “Synthesis of side-chain to side-chain cyclized petide analogs on solid supports,”Int. J. Pep. Prot. Res.(1985), 25: 171-177.
Schweitzer et al., “Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection,”Proc Natl Acad Sci U S A.(2000), 97(18):10113-9.
Sheppard, R. C., “Acid-labile resin linkage agents for use in solid phase peptide synthesis ,”Int. J. Peptide Res.(1982), 20: 451-454.
Srinivasan, M. et al., “Immunomodulatory peptides from IgSF proteins: a review,”Curr Protein Pept Sci.(2005), 6(2):185-96.
Tannous et al., “T7 RNA polymerase as a self-replicating label for antigen quantification,”Nucleic Acids Res(2002), 30(24):e140.
Walsh and Swaisgood, “AnEscherichia coliplasmid vector system for production of streptavidin fusion proteins: Expression and bioselective adsorption of streptavidin-β-galactosidase,”Biotech. Bioeng.(1994)44: 1348-1354.
William

Affiliated with

Also associated with

Rating

Binding peptidomimetics and uses of the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Binding peptidomimetics and uses of the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding peptidomimetics and uses of the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2633846